ARTICLE | Clinical News
Abaloparatide-SC regulatory update
March 14, 2017 7:56 PM UTC
FDA extended by 3 months the PDUFA date for abaloparatide-SC to treat postmenopausal osteoporosis. The new PDUFA date is June 30. Radius said FDA is reviewing information the company submitted in resp...
BCIQ Target Profiles